Page last updated: 2024-08-17

tributyrin and Cancer of Prostate

tributyrin has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altug, V; Genze, F; Gschwend, JE; Hautmann, RE; Hofer, MD; Kuefer, R; Kunzi-Rapp, K; Zorn, C1
Altug, V; Bachem, M; Gschwend, JE; Hautmann, RE; Maier, S; Martin, R; Reich, E1

Other Studies

2 other study(ies) available for tributyrin and Cancer of Prostate

ArticleYear
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer.
    British journal of cancer, 2004, Jan-26, Volume: 90, Issue:2

    Topics: Administration, Oral; Animals; Apoptosis; Blotting, Western; Butyrates; Disease Models, Animal; Gene Expression Regulation; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Retinoblastoma Protein; Transplantation, Heterologous; Triglycerides; Tumor Cells, Cultured

2004
Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines.
    International journal of cancer, 2000, Oct-15, Volume: 88, Issue:2

    Topics: Androgens; Apoptosis; Butyrates; Cell Cycle; Cell Differentiation; Cell Division; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Triglycerides; Tumor Cells, Cultured

2000